We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-3.56%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$39.9B
AUM Growth
-$3.99B
Cap. Flow
-$1.18B
Cap. Flow %
-2.97%
Top 10 Hldgs %
37.22%
Holding
1,874
New
146
Increased
562
Reduced
366
Closed
20

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$543M
2
NVDA icon
NVIDIA
NVDA
+$373M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$178M
4
ABBV icon
AbbVie
ABBV
+$149M
5
MSFT icon
Microsoft
MSFT
+$146M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$598M
2
NFLX icon
Netflix
NFLX
+$259M
3
JNJ icon
Johnson & Johnson
JNJ
+$239M
4
AMZN icon
Amazon
AMZN
+$217M
5
V icon
Visa
V
+$175M

Sector Composition

Rank Sector Weight
1 Technology 37.27%
2 Financials 12.41%
3 Healthcare 11.52%
4 Communication Services 10.2%
5 Industrials 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRA
626
DELISTED
Coterra Energy
CTRA
$2.44M 0.01%
69,512
AN icon
627
AutoNation
AN
$6.97B
$2.44M 0.01%
12,489
-47
-0.4% -$9.49K
CDW icon
628
CDW
CDW
$17.1B
$2.41M 0.01%
19,948
-949
-5% -$120K
WST icon
629
West Pharmaceutical
WST
$23.1B
$2.41M 0.01%
9,610
-11,791
-55% -$2.93M
BCO icon
630
Brink's
BCO
$5.02B
$2.36M 0.01%
22,771
+21,387
+1,545% +$2.57M
TPL icon
631
Texas Pacific Land
TPL
$28.9B
$2.34M 0.01%
4,926
INDV icon
632
Indivior Pharmaceuticals
INDV
$4.79B
$2.31M 0.01%
75,831
+72,523
+2,192% +$2.4M
RPM icon
633
RPM International
RPM
$13.7B
$2.29M 0.01%
22,994
-64,961
-74% -$7.02M
WLK icon
634
Westlake Corp
WLK
$9.46B
$2.27M 0.01%
19,432
-2,790
-13% -$271K
IONS icon
635
Ionis Pharmaceuticals
IONS
$9.35B
$2.27M 0.01%
30,213
+21,161
+234% +$1.67M
CMS icon
636
CMS Energy
CMS
$23.1B
$2.25M 0.01%
28,993
+1,877
+7% +$139K
MKC icon
637
McCormick & Company Non-Voting
MKC
$13.4B
$2.24M 0.01%
44,428
NBIX icon
638
Neurocrine Biosciences
NBIX
$17.7B
$2.24M 0.01%
17,011
-15,390
-47% -$2.04M
KRC icon
639
Kilroy Realty
KRC
$4.58B
$2.22M 0.01%
78,831
+74,964
+1,939% +$2.46M
EXE
640
Expand Energy Corp
EXE
$21.9B
$2.22M 0.01%
20,252
VSXY
641
Victoria's Secret
VSXY
$6.64B
$2.22M 0.01%
47,931
+45,889
+2,247% +$2.56M
ELAN icon
642
Elanco Animal Health
ELAN
$12.4B
$2.2M 0.01%
91,785
+1,639
+2% +$40.1K
OKLO
643
Oklo
OKLO
$7B
$2.2M 0.01%
44,281
+30,403
+219% +$2.19M
BURL icon
644
Burlington
BURL
$22B
$2.19M 0.01%
6,727
-421
-6% -$129K
RDDT icon
645
Reddit
RDDT
$32.5B
$2.18M 0.01%
16,157
+36
+0.2% +$6.13K
CRDO icon
646
Credo Technology Group
CRDO
$39.7B
$2.16M 0.01%
23,051
+5,377
+30% +$654K
COMP icon
647
Compass
COMP
$8.27B
$2.12M 0.01%
290,607
+274,749
+1,733% +$2.89M
DOC icon
648
Healthpeak Properties
DOC
$15.4B
$2.11M 0.01%
128,403
+24,426
+23% +$419K
FLNC icon
649
Fluence Energy
FLNC
$1.78B
$2.09M 0.01%
152,172
+4,300
+3% +$86.3K
QRVO icon
650
Qorvo
QRVO
$7.63B
$2.05M 0.01%
26,511
-99,745
-79% -$8.07M

Similar funds

KBC Group's Q1 2026 Portfolio in Review

As of Q1 2026, KBC Group held 1,874 positions worth $39.9B, down 9.1% from $43.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

KBC Group's Q1 2026 filing shows 146 new, 562 increased, 366 reduced and 20 closed positions. Its largest new stake was AbbVie: 669,647 shares worth $146M. The largest sale was Alphabet (Google) Class C, an estimated $598M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • KBC Group's largest Q1 2026 buy was AbbVie: 669,647 shares worth $146M.
  • KBC Group added most to Apple in Q1 2026, an estimated $543M increase.
  • KBC Group's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $598M.
  • KBC Group fully exited CyberArk in Q1 2026, selling an estimated $6.81M.
  • KBC Group's ten largest holdings make up 37% of its $39.9B portfolio in Q1 2026.
  • KBC Group opened 146 new positions and closed 20 in Q1 2026.
  • KBC Group's portfolio value fell 9.1% quarter-over-quarter to $39.9B.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.